π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Status
Unknown
Location
China, Hubei Province
Start Date
2021-08-16
Trial ID
NCT05006326
The purpose of this study is to assess the efficacy, tolerability, safety, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-25
Trial ID
NCT05114746
Treatments Being Tested
The purpose of this trial is to learn more about the effects of AAA602 and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-06-29
Trial ID
NCT06881823
Treatments Being Tested
Obtain PSMA-PET imaging preoperatively and calculate performance for predic...
Status
Completed
Location
Indiana University Health University Hospital
Start Date
2021-06-11
Trial ID
NCT04936334
Treatments Being Tested
Primary objective: i.The primary objective is to compare the diagnostic po...
Status
Recruiting
Location
Chang Gung Memorial Hospital ,Linkou
Start Date
2022-03-02
Trial ID
NCT04951817
Treatments Being Tested
Prostate cancer is the most common cancer in men. Early detection of primar...
Status
Completed
Location
Cliniques Universitaires Saint-Luc
Start Date
2019-01-24
Trial ID
NCT03183544
Treatments Being Tested
Patients undergo three diagnostic PET scans: 18F-FDG PET scan / 18F-Choline...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-01-31
Trial ID
NCT06136377
Treatments Being Tested
This clinical trial evaluates whether gallium-68 (Ga-68) prostate specific ...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-01-12
Trial ID
NCT06444412
Treatments Being Tested
This is a single-center, multi-arm, open-label, phase III trial in up to 50...
Status
Suspended
Location
Royal University Hospital
Start Date
2020-12-09
Trial ID
NCT04684628
Treatments Being Tested
Renal Cell Carcinoma (RCC) is the second most common tumor in urology. Cons...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-12-01
Trial ID
NCT05170555
Treatments Being Tested